NCT05858840

Brief Summary

Retrospective monocentric study of the outcomes of patients with neurogenic bladder, who had a urinary artificial sphincter before the age of 18 years old. Hypothesis: what was the impact of the urinary artificial sphincter on the global management of the patient.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
17

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Nov 2022

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

November 20, 2022

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 31, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 10, 2023

Completed
2 days until next milestone

First Submitted

Initial submission to the registry

April 12, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

May 15, 2023

Completed
Last Updated

May 16, 2023

Status Verified

May 1, 2023

Enrollment Period

2 months

First QC Date

April 12, 2023

Last Update Submit

May 14, 2023

Conditions

Keywords

Urinary Artificial SphincterNeurogenic BladderChildrenOutcomesRetrospective Study

Outcome Measures

Primary Outcomes (2)

  • Number of participants with refractory urinary incontinence

    Participants with urinary incontinence without response to medical treatment or catheterization

    Before surgery

  • Impact of urinary artificial sphincter on the participants' incontinence

    Three outcomes are possible: the participant is continent, the participant is continent with catheterization or the patient is incontinent.

    Through study completion, an average of 2 years

Secondary Outcomes (7)

  • Impact of bladder augmentation on participants' incontinence

    Through study completion, an average of 2 years

  • Impact of Mitrofanoff procedure on participants' incontinence

    Through study completion, an average of 2 years

  • Impact of bladder neck surgery on participants' incontinence

    Through study completion, an average of 2 years

  • Complications after urinary artificial sphincter

    Through study completion, an average of 2 years

  • Operating time

    Perioperatively

  • +2 more secondary outcomes

Interventions

Patients aged under 18 years old with UAS

Eligibility Criteria

AgeUp to 17 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

Patients younger than 18 years old who have neurogenic bladders.

You may qualify if:

  • Patients who were younger than 18 years old when they had an urinary artificial sphincter

You may not qualify if:

  • Patients who were 18 years old or older when they had an urinary artificial sphincter

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

ULorraine

Vandœuvre-lès-Nancy, Grand Est, 54500, France

Location

Related Publications (2)

  • Delgado-Miguel C, Munoz-Serrano A, Amesty V, Rivas S, Lobato R, Martinez-Urrutia MJ, Lopez-Pereira P. Artificial urinary sphincter in congenital neuropathic bladder: Very long-term outcomes. Int J Urol. 2022 Jul;29(7):692-697. doi: 10.1111/iju.14874. Epub 2022 Mar 26.

    PMID: 35340070BACKGROUND
  • Sheppard KE, Roberts JL, Blum M. Adrenocorticotropin-releasing factor down-regulates glucocorticoid receptor expression in mouse corticotrope tumor cells via an adenylate cyclase-dependent mechanism. Endocrinology. 1991 Aug;129(2):663-70. doi: 10.1210/endo-129-2-663.

    PMID: 1855464BACKGROUND

MeSH Terms

Conditions

Urinary Bladder, NeurogenicSpinal Dysraphism

Interventions

Urinary Sphincter, Artificial

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesUrinary Bladder DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsNeural Tube DefectsNervous System MalformationsCongenital AbnormalitiesCongenital, Hereditary, and Neonatal Diseases and Abnormalities

Intervention Hierarchy (Ancestors)

Prostheses and ImplantsEquipment and SuppliesArtificial OrgansSurgical Equipment

Study Officials

  • Christelle Destinval, MD

    University of Lorraine

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

April 12, 2023

First Posted

May 15, 2023

Study Start

November 20, 2022

Primary Completion

January 31, 2023

Study Completion

April 10, 2023

Last Updated

May 16, 2023

Record last verified: 2023-05

Data Sharing

IPD Sharing
Will not share

In the name of anonymization the investigators won't share individual participant data

Locations